Unknown OBSERVATIONAL NCT05250128

The Significance of Circulating Microvesicles in Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (MICROBOPH)

Characterization and Significance of Circulating Microvesicles in Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

Sponsor: University Hospital, Strasbourg, France

Conditions Circulating Markers of Endothelium Damage Circulating Microvesicles Obstructive Pulmonary Disease Pulmonary Hypertension Due to Chronic

Interventions Catheterization

Updated 5 times since 2022 Last updated: Jun 21, 2022 Started: Sep 30, 2022 Primary completion: Sep 30, 2022 Completion: Sep 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05250128, this observational or N/A phase trial focuses on Circulating Markers of Endothelium Damage and Circulating Microvesicles and remains ongoing. Sponsored by University Hospital, Strasbourg, France, it has been updated 5 times since 2022, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Nov 2025 — Present [monthly]

Unknown

Status: Not Yet Recruiting → Unknown
Sep 2024 — Nov 2025 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Jul 2022 — Jul 2024 [monthly]

Not Yet Recruiting
Mar 2022 — Jul 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Strasbourg, France

Data source: University Hospital, Strasbourg, France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Strasbourg, France